SkinBioTherapeutics

About:

The SkinBioTherapeutics platform applies research discoveries made on the activities of lysates derived from probiotic bacteria.

Website: http://www.skinbiotherapeutics.com/

Twitter/X: SkinBioT

Top Investors: Seneca Partners, Premier Miton Investors, Cynosure Capital

Description:

The SkinBioTherapeutics platform applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to the skin. The Company has shown that the SkinBiotix® platform can improve the barrier effect of skin models, improve repair, and reduce bacterial load.

Total Funding Amount:

5.68M GBP

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Macclesfield, Cheshire East, United Kingdom

Founded Date:

2015-01-01

Contact Email:

stephen.france(AT)skinbiotherapeutics.com

Founders:

Catherine O'Neill

Number of Employees:

1-10

Last Funding Date:

2024-08-02

IPO Status:

Public

Industries:

© 2025 bioDAO.ai